McIntosh G C, Olshan A F, Baird P A
School of Medicine, University of Wisconsin, Madison, USA.
Epidemiology. 1995 May;6(3):282-8. doi: 10.1097/00001648-199505000-00016.
Previous studies have shown that advanced paternal age is associated with an increase in new dominant mutations that may result in some rare congenital anomalies or syndromes in the offspring. Nevertheless, few epidemiologic studies have evaluated the effect of paternal age on the risk of more common birth defects. We examined data from the British Columbia Health Surveillance Registry, which included a total of 9,660 cases of birth defects (22 specific defect groups). We chose matched controls from the birth files of British Columbia (1952-1973). With the exception of an unusual change in direction in the 45-49 years age category, we found a general pattern of increasing relative risk estimates (adjusted for maternal age and other factors) with increasing paternal age for neural tube defects, congenital cataracts, reduction defects of the upper limb, and Down syndrome. For example, the adjusted relative risk estimates for neural tube defects in the offspring were 1.2 (for fathers age 30-34 years relative to 25-29 years); 1.3 (35-39); 1.6 (40-44); 0.6 (45-49); and 2.3 (men 50 years and older). Men under 20 years of age were also at increased risk for fathering children with birth defects such as neural tube defects, hypospadias, cystic kidney, and Down syndrome. We hypothesize that among certain commonly observed birth defects a subgroup of cases may be due to new, unrecognized dominant mutations.
以往的研究表明,父亲年龄偏大与新的显性突变增加有关,这些突变可能导致后代出现一些罕见的先天性异常或综合征。然而,很少有流行病学研究评估父亲年龄对更常见出生缺陷风险的影响。我们研究了不列颠哥伦比亚省健康监测登记处的数据,其中包括总共9660例出生缺陷病例(22个特定缺陷组)。我们从不列颠哥伦比亚省的出生记录(1952 - 1973年)中选取了匹配的对照组。除了45 - 49岁年龄组出现方向异常变化外,我们发现对于神经管缺陷、先天性白内障、上肢发育不全缺陷和唐氏综合征,随着父亲年龄的增加(调整了母亲年龄和其他因素),相对风险估计值呈现总体上升趋势。例如,后代神经管缺陷的调整后相对风险估计值为:1.2(父亲年龄30 - 34岁相对于25 - 29岁);1.3(35 - 39岁);1.6(40 - 44岁);0.6(45 - 49岁);以及2.3(50岁及以上男性)。20岁以下的男性生育患有神经管缺陷、尿道下裂、多囊肾和唐氏综合征等出生缺陷孩子的风险也会增加。我们推测,在某些常见的出生缺陷中,一部分病例可能是由于新的、未被认识的显性突变所致。